News

United Imaging Announces the First of Several New U.S. Product Launches For RSNA

The first uMI Panvivo in the world lands at the growing Pueblo Medical Imaging in Nevada. HOUSTON, Nov. 21, 2024…

1 year ago

Nearly Half of U.S. Workers Say They Won’t Deplete Allotted Vacation By Year End

85% Percent of Workers Say It Would Be Beneficial for Employers to Mandate Taking Vacation Days   ARLINGTON, Va., Nov. 21,…

1 year ago

Aquila Recognized as an Avetta 2024 Diversity Leader for Advancing Workplace Inclusion

MIAMI, Nov. 21, 2024 /PRNewswire/ -- Aquila is proud to announce its recognition as an Avetta 2024 Diversity Leader. This…

1 year ago

CliniComp Named Sole EHR Provider in “Top 100 Healthcare Technology Company” of 2024 by The Healthcare Technology Report

Company helps hospitals achieve world-class, patient-centric EHR functionality without the financial and operational burdens of traditional solutions SAN DIEGO, Nov.…

1 year ago

PerfectServe Positioned Furthest for Completeness of Vision in 2024 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

Company views recognition as a reflection of its commitment to advancing clinical communication and productivity for improved care delivery in…

1 year ago

Zero Candida Announces TSX Venture Exchange Listing Date

VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology…

1 year ago

Brooks Rehabilitation, Nemours Children’s Health, Wolfson Children’s Hospital and UF Health Jacksonville Partner to Enhance Pediatric Care

JACKSONVILLE, Fla., Nov. 21, 2024 /PRNewswire/ -- By combining resources and expertise, Brooks Rehabilitation, Nemours Children's Health, Jacksonville, Wolfson Children's…

1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

1 year ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF…

1 year ago